Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 1R01DA022122-01A1 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Institute on Drug Abuse (NIDA) | NIH |
| APT Foundation, Inc. | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To conduct a randomized clinical trial (RCT) of a community-friendly behavioral intervention designed to reduce HIV risk behavior among injection drug users (IDUs) in drug treatment by comparing risk-behavior outcomes of four weekly intervention sessions with a time-and-attention-matched control condition.
This research study will test the effects of CHRP, a community-friendly risk reduction intervention, which is based on the Information-Motivation-Behavioral Skills model of health behavior change (IMB; Fisher & Fisher, 1992), and, thus, is designed to enhance knowledge, motivation, and behavior skills for reducing drug- and sex-related HIV risk behaviors. Outcomes assessed will include urine toxicology screens, self-reported HIV drug- and sex-related HIV risk behavior, HIV/AIDS knowledge, risk reduction motivation, and risk reduction behavioral skills.
To measure the effects of CHRP, the investigators are proposing a two-condition (standard of care plus the CHRP intervention vs. standard of care plus a time-and-attention matched control condition) randomized design, balancing for participant gender. The investigators will assess participants at baseline, immediately post-intervention (i.e., at 4 weeks), and at 3-, 6-, and 12-month measurement points following the intervention. This assessment approach will allow the investigators to examine the trajectory of HIV risk reduction change including the decay or emergence of intervention effects.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| CHRP Group | Experimental | Patients assigned to Community-friendly Health Recovery Program (CHRP) will receive a weekly HIV risk reduction group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. The CHRP intervention is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). |
|
| Control Condition | Active Comparator | The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Community-friendly Health Recovery Program | Behavioral | Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management). |
|
| Measure | Description | Time Frame |
|---|---|---|
| Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Baseline |
| Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Immediately Post-Intervention, at 4 weeks |
| Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | 3-month follow up |
| Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | 6-month follow up |
| Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | 12-month follow up |
| Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | Baseline |
| Safer Drug Use (0-4) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Michael C Copenhaver, Ph.D. | University of Connecticut | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| APT Foundation | New Haven | Connecticut | 06519 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 1594721 | Background | Fisher JD, Fisher WA. Changing AIDS-risk behavior. Psychol Bull. 1992 May;111(3):455-74. doi: 10.1037/0033-2909.111.3.455. | |
| 25101381 | Background | Institute of Medicine (US) Committee on Community-Based Drug Treatment; Lamb S, Greenlick MR, McCarty D, editors. Bridging the Gap between Practice and Research: Forging Partnerships with Community-Based Drug and Alcohol Treatment. Washington (DC): National Academies Press (US); 1998. Available from http://www.ncbi.nlm.nih.gov/books/NBK230402/ |
| Label | URL |
|---|---|
| Center for Health, Intervention, and Prevention | View source |
Not provided
292 participants did not meet the study's inclusion criteria, 36 participants missed the initial interview appointment, and 16 participants were ineligible due to already being enrolled in another study.
A total of 648 participants were screened from March 2007 through August 2010 from a methadone maintenance program in New Haven, Connecticut.
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | CHRP Group | Patients assigned to Community-friendly Health Recovery Program (CHRP) will receive a weekly HIV risk reduction group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. The CHRP intervention is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Community-friendly Health Recovery Program : Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management). |
| FG001 | Control Condition | The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Time-and-Attention-Matched Control Condition : Four weekly support groups and routine clinical services (i.e., daily methadone and case management). |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Study Intervention |
| |||||||||||||
| Post Intervention Assessment (at Week 4) |
| |||||||||||||
| 3-Month Follow-up Assessment |
| |||||||||||||
| 6-Month Follow-up Assessment |
| |||||||||||||
| 12-Month Follow-up Assessment |
|
Only participants who completed all 5 time points on drug-risk reduction knowledge and personal motivation for safer drug use were included in the analysis (i.e., 95 participants for the intervention group and 90 participants for the control group). For all other variables, the participants analyzed for the two groups were 97 and 92, respectively.
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | CHRP Group | Patients assigned to Community-friendly Health Recovery Program (CHRP) will receive a weekly HIV risk reduction group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. The CHRP intervention is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Community-friendly Health Recovery Program : Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management). |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Posted | Mean | Standard Error | Percentage of correct steps | Baseline |
|
March 2007 through August 2011.
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | CHRP Group | Patients assigned to Community-friendly Health Recovery Program (CHRP) will receive a weekly HIV risk reduction group level intervention led by two facilitators trained and supervised by the PI, a licensed clinical psychologist. The CHRP intervention is a substantially shortened version of the comprehensive Holistic Health Recovery Program (HHRP)-based interventions that have been identified as demonstrating evidence of effectiveness in two randomized clinical trials. The CHRP, which includes four 50-minute groups (1 group per week), will contain only content that relates explicitly to drug- or sex-related HIV risk reduction. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Community-friendly Health Recovery Program: Four weekly HIV risk-reduction groups and routine clinical services (i.e., daily methadone and case management). |
Not provided
Not provided
The drug-risk reducing effects of methadone may have restricted our ability to detect intervention effects on drug-related outcomes. Participants may have also been reluctant to report HIV risk related behaviors.
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Michael M. Copenhaver, Ph.D. | University of Connecticut | 860 208-3632 | michael.copenhaver@uconn.edu |
Not provided
| ID | Term |
|---|---|
| D009293 | Opioid-Related Disorders |
| D012309 | Risk-Taking |
| ID | Term |
|---|---|
| D000079524 | Narcotic-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Time-and-Attention-Matched Control Condition | Behavioral | Four weekly support groups and routine clinical services (i.e., daily methadone and case management). |
|
Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. |
| Immediately Post-Intervention, at 4 weeks |
| Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | 3-month follow up |
| Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | 6-month follow up |
| Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | 12-month follow up |
| Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | Baseline |
| Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | Immediately Post-Intervention, at 4 weeks |
| Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | 3-month follow up |
| Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | 6-month follow up |
| Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles"). | 12-month follow up |
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Baseline |
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Immediately Post-Intervention, at 4 weeks |
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | 3-month follow up |
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | 6-month follow up |
| Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | 12-month follow up |
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Baseline |
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Immediately Post-Intervention, at 4 weeks |
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | 3-month follow up |
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | 6-month follow up |
| Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | 12-month follow up |
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Baseline |
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Immediately Post-Intervention, at 4 weeks |
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | 3-month follow up |
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | 6-month follow up |
| Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | 12-month follow up |
| Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Baseline |
| Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Immediately Post-Intervention, at 4 weeks |
| Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | 3-month follow up |
| Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | 6-month follow up |
| Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | 12-month follow up |
| Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Baseline |
| Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Immediately Post-Intervention, at 4 weeks |
| Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | 3-month follow up |
| Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | 6-month follow up |
| Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | 12-month follow up |
| Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Baseline |
| Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Immediately Post-Intervention, at 4 weeks |
| Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | 3-month follow up |
| Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | 6-month follow up |
| Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | 12-month follow up |
| Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Baseline |
| Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Immediately Post-Intervention, at 4 weeks |
| Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | 3-month follow up |
| Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | 6-month follow up |
| Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | 12-month follow up |
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Baseline |
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Immediately Post-Intervention, at 4 weeks |
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | 3-month follow up |
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | 6-month follow up |
| Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | 12-month follow up |
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Baseline |
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Immediately Post-Intervention, at 4 weeks |
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | 3-month follow up |
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | 6-month follow up |
| Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | 12-month follow up |
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Baseline |
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Immediately Post-Intervention, at 4 weeks |
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | 3-month follow up |
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | 6-month follow up |
| Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | 12-month follow up |
| NOT COMPLETED |
|
| NOT COMPLETED |
|
| NOT COMPLETED |
|
| NOT COMPLETED |
|
| BG001 | Control Condition | The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Time-and-Attention-Matched Control Condition : Four weekly support groups and routine clinical services (i.e., daily methadone and case management). |
| BG002 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Region of Enrollment | Number | participants |
|
| OG001 | Control Condition | The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Time-and-Attention-Matched Control Condition : Four weekly support groups and routine clinical services (i.e., daily methadone and case management). |
|
|
| Primary | Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Posted | Mean | Standard Error | Percentage of correct steps | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Posted | Mean | Standard Error | Percentage of correct steps | 3-month follow up |
|
|
|
| Primary | Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Posted | Mean | Standard Error | Percentage of correct steps | 6-month follow up |
|
|
|
| Primary | Demonstrated Drug Risk Reduction Skills (0-100%) | Participants' HIV risk reduction skills were assessed by having participants demonstrate the steps necessary to properly clean a needle/syringe. | Posted | Mean | Standard Error | Percentage of correct steps | 12-month follow up |
|
|
|
| Primary | Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Safer Drug Use (0-4) | Participants completed a self-reported assessment that asks about IV-sharing behavior and were assessed on a scale of 0-4, with higher scores indicating safer drug use. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles") and were rated on a scale of 0 to 1 (higher values representing greater risk reduction knowledge). | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Drug-related HIV-risk Reduction Knowledge (0-1) | Participants completed an assessment that covers information about drug-related HIV-risk reduction (e.g.,"If an HIV+ person shared needles with another HIV+ person, they don't need to clean the needles"). | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Personal Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce HIV risk behavior (e.g., "I plan to always use clean needles if I shoot up drugs during the next six months") and rated on a scale of 1 to 5, with higher scores indicating stronger motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Social Motivation to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce HIV risk behavior (e.g., "Most people who are important to me think I should always clean my needles before I share them with someone else during the next three months") and rated on a scale of 1 to 5, with higher scores indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Self-efficacy to Reduce Drug-related HIV-Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing HIV risk behavior (e.g., "How hard would it be for you to always use condoms") and rated on a scale of 1 to 5, with higher scores indicating greater self-efficacy to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | Baseline |
|
|
|
| Primary | Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | 3-month follow up |
|
|
|
| Primary | Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | 6-month follow up |
|
|
|
| Primary | Female Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a female condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | 12-month follow up |
|
|
|
| Primary | Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | Baseline |
|
|
|
| Primary | Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | 3-month follow up |
|
|
|
| Primary | Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | 6-month follow up |
|
|
|
| Primary | Male Condom Skills (0-100%) | Participants' HIV risk reduction behavioral skills were assessed based on the percentage of correct necessary steps demonstrated to properly select and apply a male condom using a replica. | Posted | Mean | Standard Error | percentage of correct steps | 12-month follow up |
|
|
|
| Primary | Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Condom Use (0-4) | Participants were asked: "In the past week, how much of the time did you use a condom or other latex protection when you had oral, anal, or vaginal sex?" and rated on scale of 0 to 4, with indicating greater condom use. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Sex-related HIV-risk Reduction Knowledge (0-1) | Participants' knowledge of sex-related HIV-risk reduction was assessed by being asked: "If an HIV positive person only has sex with another HIV positive person, they don't need to use condoms" and rated on a scale of 0 to 1, with a higher score indicating greater HIV-risk reduction knowledge. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Personal Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their personal motivation to reduce sex-related HIV-risk behavior (e.g., "Always using condoms during sexual intercourse during the next three months would be good") and were rated on a scale of 1 to 5, with a higher score indicating greater personal motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Social Motivation to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their social motivation to reduce sex-related HIV-risk behavior (e.g., "Most people who are important to me think I should always use condoms during sexual intercourse in the next three months") and were rated on a scale of 1 to 5, with a higher score indicating stronger social motivation to reduce HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| Primary | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Baseline |
|
|
|
| Primary | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | Immediately Post-Intervention, at 4 weeks |
|
|
|
| Primary | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 3-month follow up |
|
|
|
| Primary | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 6-month follow up |
|
|
|
| Primary | Self-efficacy to Reduce Sex-related HIV- Risk Behavior (1-5) | Participants completed a questionnaire assessing their self-efficacy about reducing sex-related HIV-risk behavior (e.g., "If asked, I am confident I could demonstrate how to use male condom and female condoms correctly") and were rated on a scale of 1 to 5, with a higher score indicating greater self-efficacy to reduce sex-related HIV-risk behavior. | Posted | Mean | Standard Error | units on a scale | 12-month follow up |
|
|
|
| 0 |
| 149 |
| 0 |
| 149 |
| EG001 | Control Condition | The time-and-attention-matched control condition for the proposed research will be a time and contact-matched, non-contaminating support group for individuals in recovery modeled after similar groups offered in the community. There will be no overlap between the content of the comparison intervention and experimental intervention although the basic structure will be the same. Thus, each participant will be asked to attend four 50-minute weekly group sessions led by two trained facilitators. Participants in both conditions will receive routine clinical services (i.e., daily methadone and case management). Time-and-Attention-Matched Control Condition: Four weekly support groups and routine clinical services (i.e., daily methadone and case management). | 0 | 155 | 0 | 155 |
Not provided
Not provided
Not provided
| D001519 | Behavior |